1 |
Coemans M, Süsal C, Döhler B, et al. Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015[J]. Kidney Int, 2018, 94(5):964-973.
|
2 |
Thongprayoon C, Hansrivijit P, Leeaphorn N, et al. Recent advances and clinical outcomes of kidney transplantation[J]. J Clin Med, 2020, 9(4):1193.
|
3 |
Fishman JA. Infection in solid-organ transplant recipients[J]. N Engl J Med, 2007, 357(25):2601-2614.
|
4 |
Kinnunen S, Karhapää P, Juutilainen A, et al. Secular trends in infection-related mortality after kidney transplantation[J]. Clin J Am Soc Nephrol, 2018, 13(5):755-762.
|
5 |
Vanichanan J, Udomkarnjananun S, Avihingsanon Y, et al. Common viral infections in kidney transplant recipients[J]. Kidney Res Clin Pract, 2018, 37(4):323-337.
|
6 |
Farmer JR, DeLelys M. Flow cytometry as a diagnostic tool in primary and secondary immune deficiencies[J]. Clin Lab Med, 2019, 39(4):591-607.
|
7 |
Fernández-Ruiz M, López-Medrano F, Aguado JM. Predictive tools to determine risk of infection in kidney transplant recipients[J]. Expert Rev Anti Infect Ther, 2020, 18(5):423-441.
|
8 |
Liu W, Wang K, Zhao Y, et al. Clinical relevance of a CD4+ T cell immune function assay in the diagnosis of infection in pediatric living-donor liver transplantation[J]. Exp Ther Med, 2019, 18(5):3823-3828.
|
9 |
Gardiner BJ, Nierenberg NE, Chow JK, et al. Absolute lymphocyte count: a predictor of recurrent cytomegalovirus disease in solid organ transplant recipients[J]. Clin Infect Dis, 2018, 67(9):1395-1402.
|
10 |
Fernández-Ruiz M, López-Medrano F, Allende LM, et al. Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation[J]. Transpl Int, 2014, 27(7):674-685.
|
11 |
Struijk GH, Gijsen AF, Yong SL, et al. Risk of pneumocystis jiroveci pneumonia in patients long after renal transplantation[J]. Nephrol Dial Transplant, 2011, 26(10):3391-3398.
|
12 |
Prakash K, Chandorkar A, Saharia KK. Utility of CMV-specific immune monitoring for the management of CMV in solid organ transplant recipients: a clinical update[J]. Diagnostics, 2021, 11(5):875.
|
13 |
Navarro D, Fernández-Ruiz M, Aguado JM, et al. Going beyond serology for stratifying the risk of CMV infection in transplant recipients[J]. Rev Med Virol, 2019, 29(1):e2017.
|
14 |
López-Oliva MO, Martínez V, Rodríguez-Sanz A, et al. Pre-transplant assessment of pp65-specific CD4 T cell responses identifies CMV-seropositive patients treated with rATG at risk of late onset infection[J]. Clin Immunol, 2020, 211:108329.
|
15 |
Schachtner T, Stein M, Reinke P. CMV-specific T cell monitoring offers superior risk stratification of CMV-seronegative kidney transplant recipients of a CMV-seropositive donor[J]. Transplantation, 2017, 101(10):e315-e325.
|
16 |
Calarota SA, Zelini P, De Silvestri A, et al. Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients[J]. Transplantation, 2012, 93(1):112-119.
|
17 |
Thibaudin D, Alamartine E, Mariat C, et al. Long-term kinetic of T-lymphocyte subsets in kidney-transplant recipients: influence of anti-T-cell antibodies and association with posttransplant malignancies[J]. Transplantation, 2005, 80(10):1514-1517.
|
18 |
Calarota SA, Chiesa A, Silvestri AD, et al. T-lymphocyte subsets in lung transplant recipients: association between nadir CD4 T-cell count and viral infections after transplantation[J]. J Clin Virol, 2015, 69:110-116.
|
19 |
王勤拯,王峰,朱晓丹. 外周血淋巴细胞亚群变化在肝移植术后患者早期感染中的意义[J]. 精准医学杂志,2020, 35(4):372-375.
|